Navigation Links
Ferring to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
Date:2/12/2013

SAN FRANCISCO, Feb. 12, 2013 /PRNewswire/ -- Ferring Pharmaceuticals will present pivotal Phase 3 efficacy and safety data from its EXPEDITE* study for its investigational controlled release misoprostol vaginal insert (MVI) at the 33rd annual meeting of the Society for Maternal-Fetal Medicine (SMFM) in San Francisco, February 11 - 16. These and other research findings formed the basis for Ferring's New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) supporting the use of the controlled release MVI as a treatment option for cervical ripening as part of the labor induction process.

Studies accepted for presentation include

  • An oral presentation on Sat., Feb. 16 (9 a.m. – 9:15 a.m. PST), titled "Efficacy and safety of misoprostol vaginal insert compared with dinoprostone vaginal insert for labor induction" (lead author: Deborah A. Wing , MD, University of California, Irvine); and
  • A poster presentation on Thurs., Feb. 14 (3:30 p.m. – 5:30 p.m. PST), titled "Comparison of misoprostol vaginal insert and dinoprostone vaginal insert: incidence of treatment-emergent adverse events" (lead author: Stacey Ehrenberg-Buchner , MD, University of Michigan Health System).

*The EXPEDITE Study: A Phase 3, double blind, randomized, multicenter study of exogenous prostaglandin comparing the efficacy and safety of the misoprostol vaginal insert (MVI) 200 mcg to the dinoprostone vaginal insert for reducing time to vaginal delivery in pregnant women at term.

For further information, contact:
Leila Boukassi
MSL New York
leila.boukassi@mslgroup.com; 646.500.7735 

About Ferring Pharmaceuticals:
Ferring Pharmaceuticals is a research-driven speciality biopharmaceutical company, active in global markets. The company identifies, develops and markets innovative products in the areas of general and pediatric endocrinology, gastroenterology, infertility, obstetrics/gynecology, orthopedics and urology. For more information, call 1-888-FERRING (1-888-337-7464) or visit www.FerringUSA.com.

 


'/>"/>
SOURCE Ferring Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
2. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
3. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
4. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
5. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
6. Isis Reports Financial Results and Highlights for First Quarter 2012
7. Delcath Highlights First Quarter 2012 And Recent Accomplishments
8. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
9. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
10. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
11. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/3/2020)... ... January 03, 2020 , ... In Partnership with the Smiles for ... underinsured individuals at its Burleson, TX office on February 8th. , Dental services provided ... cleanings and extractions . For more information, please visit the Monarch ...
(Date:1/3/2020)... (PRWEB) , ... January 03, 2020 , ... ... division by Montreal-based AlayaCare. The combined business will offer enterprise solutions for ... acquire all Procura assets, people and customer contracts and will move forward under ...
(Date:1/2/2020)... ... January 02, 2020 , ... ... address all levels of psychiatric-mental health nursing administration, education, practice, and research. ... 1800+ registered and advanced practice nurses. Nurses from varied backgrounds are encouraged ...
Breaking Medicine Technology:
(Date:1/12/2020)... ... January 12, 2020 , ... Cecelia Health ... York City, has continually innovated for over a decade to transform lives and ... device companies and self-insured employers. By optimizing the mix of expert clinician and ...
(Date:1/10/2020)... ... January 10, 2020 , ... Ziegler, a specialty investment bank, ... Ltd. on its partnership with US Radiology Specialists (“USRS”), backed by private equity ... is the largest private practice radiology group and outpatient imaging operator in Tucson, ...
(Date:1/10/2020)... ... January 10, 2020 , ... The value of healthy vision ... via a preventative approach. Leading eye care doctor, Brent Bellotte MD., champions such proactive ... common eye diseases. , Eyesight is something that many take for granted until a ...
(Date:1/10/2020)... ... January 10, 2020 , ... The Board of ... Emergency Nurse (CPEN) specialty nursing certification program has been reaccredited by the ... national board certification earned by registered nurses (RNs) who demonstrate advanced knowledge ...
(Date:1/8/2020)... ... January 08, 2020 , ... Mirror Mirror Beauty ... 2019 Best of Memorial Readers’ Choice Awards. Located adjacent to Vitenas Cosmetic ... MedSpa in Memorial reflects Mirror Mirror Beauty Boutique’s commitment to the hottest noninvasive ...
Breaking Medicine News(10 mins):